HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glycolic acid inhibits enzymatic, hemorrhagic and edema-inducing activities of BaP1, a P-I metalloproteinase from Bothrops asper snake venom: insights from docking and molecular modeling.

Abstract
Glycolic acid (GA) (2-Hydroxyethanoic acid) is widely used as chemical peeling agent in Dermatology and, more recently, as a therapeutic and cosmetic compound in the field of skin care and disease treatment. In this work we tested the inhibitory ability of glycolic acid on the enzymatic, hemorrhagic and edema-inducing activities of BaP1, a P-I metalloproteinase from Bothrops asper venom, which induces a variety of toxic actions. Glycolic acid inhibited the proteolytic activity of BaP1 on azocasein, with an IC₅₀ of 1.67 mM. The compound was also effective at inhibiting the hemorrhagic activity of BaP1 in skin and muscle in experiments involving preincubation of enzyme and inhibitor prior to injection. When BaP1 was injected i.m. and then, at the same site, different concentrations of glycolic acid were administered at either 0 or 5 min, 7 mM solutions of the inhibitor partially abrogated hemorrhagic activity when administered at 0 min. Moreover, glycolic acid inhibited, in a concentration-dependent manner, edema-forming activity of BaP1 in the footpad. In order to have insights on the mode of action of glycolic acid, UV-vis and intrinsic fluorescence studies were performed. Results of these assays suggest that glycolic acid interacts directly with BaP1 and chelates the Zn²⁺ ion at the active site. These findings were supported by molecular docking results, which suggested that glycolic acid forms hydrogen bonds with residues Glu143, Arg110 and Ala111 of the enzyme. Additionally, molecular modeling results suggest that the inhibitor chelates Zn²⁺, with a distance of 3.58 Å, and may occupy part of substrate binding cleft of BaP1. Our results suggest that glycolic acid is a candidate for the development of inhibitors to be used in snakebite envenomation.
AuthorsJaime Andrés Pereañez, Arley Camilo Patiño, Paola Rey-Suarez, Vitelbina Núñez, Isabel Cristina Henao Castañeda, Alexandra Rucavado
JournalToxicon : official journal of the International Society on Toxinology (Toxicon) Vol. 71 Pg. 41-8 (Sep 2013) ISSN: 1879-3150 [Electronic] England
PMID23726855 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Caseins
  • Chelating Agents
  • Glycolates
  • Snake Venoms
  • azocasein
  • glycolic acid
  • BaP1 metalloproteinase
  • Metalloendopeptidases
  • Zinc
Topics
  • Animals
  • Bothrops
  • Caseins (metabolism)
  • Catalytic Domain (drug effects)
  • Chelating Agents (chemistry)
  • Edema (drug therapy)
  • Glycolates (pharmacology)
  • Hemorrhage (drug therapy)
  • Inhibitory Concentration 50
  • Metalloendopeptidases (antagonists & inhibitors, toxicity)
  • Mice
  • Molecular Docking Simulation
  • Muscle, Skeletal (drug effects, metabolism)
  • Proteolysis (drug effects)
  • Skin (drug effects, metabolism)
  • Snake Bites (drug therapy)
  • Snake Venoms (toxicity)
  • Zinc (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: